The Impact of AI on Drug Target Discovery and the Personalization of Healthcare - with Leo Barella of Takeda

Today’s guest is Leo Barella, Senior Vice President and Chief Technology Officer at Takeda. He joins Senior Editor Matthew DeMello on this week’s program to talk about the biggest challenges facing the healthcare and life science spaces and where we’re starting to see AI capabilities and use cases emerge, particularly in drug targeting development. Later, he explains what he sees as an emerging market for healthcare microservices evolving from expanding data capabilities.